(Q41650109)

6 October 2017

title

Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort (English)

1 reference

6 October 2017

0 references

1 reference

Manolio T

3

0 references

Steven Kittner

6

object named as

Kittner SJ

1 reference

6 October 2017

White RH

1

1 reference

6 October 2017

McBurnie MA

2

1 reference

6 October 2017

Furberg CD

4

1 reference

6 October 2017

Gardin JM

5

1 reference

6 October 2017

Bovill E

7

1 reference

6 October 2017

Knepper L

8

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

American Journal of Medicine

6 October 2017

published in

1 reference

6 October 2017

volume

106

1 reference

6 October 2017

issue

2

1 reference

6 October 2017

page(s)

165-171

1 reference

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Stroke Prevention in Atrial Fibrillation Study. Final results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Canadian atrial fibrillation anticoaguiation (CAFA) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Antithrombotic therapy in atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Survey of use of anticoagulation in patients with atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Physician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Atrial fibrillation and stroke prevention with warfarin in the long-term care setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

The Cardiovascular Health Study: design and rationale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Recruitment of adults 65 years and older as participants in the cardiovascular health study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Factor II, VII, IX and X concentrations in patients receiving long term warfarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Recent national patterns of warfarin use in atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Variation in the use of cardiac procedures after acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900389-1

10.1016/S0002-9343(98)00389-1

7 January 2021

Identifiers

DOI

1 reference

6 October 2017

1 reference